In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia

Citation
Sh. Lim et al., In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia, BONE MAR TR, 22(12), 1998, pp. 1185-1190
Citations number
11
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
Journal title
BONE MARROW TRANSPLANTATION
ISSN journal
02683369 → ACNP
Volume
22
Issue
12
Year of publication
1998
Pages
1185 - 1190
Database
ISI
SICI code
0268-3369(199812)22:12<1185:IVCLCI>2.0.ZU;2-R
Abstract
We previously showed that in chronic myeloid leukaemia (CML), it is possibl e to induce costimulatory molecules, CD80/CD86, on leukaemia cells by cultu ring adherent peripheral blood mononuclear cells from these patients with I L-4 and GM-CSF, In addition to the expression of CD80/CD86 molecules, some of the leukaemia cells also expressed the dendritic cell marker, CD1a, When these leukaemia cells were used in mixed lymphocyte leukaemia reactions, t hey mediated antologous T cell proliferation not seen when fresh leukaemia cells were used as the stimulator cells. In this study, we showed that rein fusion of these immunogenic leukaemia cells to the autologous hosts resulte d in priming in vivo of T cells so that they could respond to subsequent re challenge in vitro with fresh autologous leukaemia cells. Although cytotoxi c T cells against leukaemia cells were not demonstrated, these T cells coul d proliferate and produce interferon-gamma when cocultured in vitro with th e leukaemia cells, Our findings therefore provide further evidence for the immunogenicity of these cultured leukaemia cells in CML.